ANDA 78577, held by Hospira. Levofloxacin.
As of Nov 16, 2026, ANDA 78577 (Levofloxacin), held by Hospira, was first approved by FDA on Aug 12, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 2015 | Original application | Approved |
| LevofloxacinEQ 500MG/20ML (EQ 25MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| LevofloxacinEQ 750MG/30ML (EQ 25MG/ML) · injectable;injection | Levofloxacin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters